Hepatitis C Virus Therapy
New hepatitis C virus therapy research from D. Breilh and colleagues discussed
Published in Hepatitis Weekly, August 31st, 2009
Scientists discuss in 'Impact of ribavirin plasma level on sustained virological response in patients treated with pegylated interferon and ribavirin for chronic hepatitis C' new findings in hepatitis C virus. "The main goal of therapy in hepatitis C virus (HCV) infection is to achieve a sustained virological response (SVR). However, the impact of the pharmacological properties of ribavirin on the SVR has not been fully investigated," scientists in Bordeaux, France report.
"To evaluate, through a prospective study, the association between ribavirin plasma level and SVR response in HCV patients treated with pegylated interferon (PEG-IFN) and ribavirin. Patients treated...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2009-08-31)
More Articles from Hepatitis Weekly
- University of Leeds
Hepatitis C virus channels efforts into cell survival - Dengue Fever
Recent findings from D.R. Rodriguez and co-authors highlight research in dengue fever - Hepatitis A Virus
New hepatitis A virus study findings have been reported by scientists at Dongguk University - Hepatitis B Virus
New hepatitis B virus findings from S. Telaku and co-researchers published - Hepatitis B Virus
Scientists at North Carolina State University target hepatitis B virus - Hepatitis B Virus
Studies from Chang-Gung University in the area of hepatitis B virus published - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
